Basonuclin: a novel mammalian maternal-effect gene

Area of Science:

• Reproductive Biology
• Developmental Biology
• Molecular Genetics

Background:

• Basonuclin is a zinc-finger protein highly expressed in oocytes.
• Maternal-effect genes are essential, with their products supplied by the mother to support early embryonic development.
• The specific role of basonuclin in oogenesis and early embryogenesis remains largely unexplored.

Purpose of the Study:

• To investigate the function of basonuclin in mouse oocytes and its impact on female fertility.
• To determine if basonuclin qualifies as a maternal-effect gene.
• To elucidate the molecular mechanisms underlying basonuclin's role in oogenesis and early development.

Main Methods:

• Utilized a transgenic-RNAi approach to specifically knock down basonuclin in mouse oocytes.
• Assessed female fertility, oocyte morphology, and transcriptional activity (RNA polymerase I and II).
• Examined the developmental potential of fertilized basonuclin-deficient oocytes.

Main Results:

• Basonuclin knockdown in oocytes resulted in female sub-fertility.
• Oocyte-specific basonuclin deficiency disrupted RNA polymerase I and II transcription and caused morphological abnormalities.
• Despite some oocytes reaching metaphase II arrest, fertilized basonuclin-deficient eggs failed to progress beyond the two-cell stage, indicating pre-implantation failure.

Conclusions:

• Basonuclin is identified as a novel mammalian maternal-effect gene.
• Unlike previously known maternal-effect genes, basonuclin appears to play a direct role in oogenesis.
• Basonuclin deficiency perturbs both oogenesis and early embryonic development, explaining the observed sub-fertility phenotype.